Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus.
Specchia ML, de Waure C, Gualano MR, Doria A, Turchetti G, Pippo L, Di Nardo F, Capizzi S, Cadeddu C, Kheiraoui F, Iaccarino L, Pierotti F, Palla I, Veneziano MA, Gliubizzi D, Sferrazza A, Nicolotti N, Porcasi R, La Torre G, Di Pietro ML, Ricciardi W. Specchia ML, et al. Among authors: porcasi r. Biomed Res Int. 2014;2014:704207. doi: 10.1155/2014/704207. Epub 2014 Aug 17. Biomed Res Int. 2014. PMID: 25243173 Free PMC article.
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas.
Turdo A, Gaggianesi M, D'Accardo C, Porcelli G, Bella SD, Cricchio D, Pillitteri I, Porcasi R, Lo Iacono M, Verona F, Modica C, Roozafzay N, Florena AM, Stassi G, Mancuso S, Todaro M. Turdo A, et al. Among authors: porcasi r. Front Immunol. 2023 Nov 14;14:1266265. doi: 10.3389/fimmu.2023.1266265. eCollection 2023. Front Immunol. 2023. PMID: 38035116 Free PMC article.
The chaperone system in glioblastoma multiforme and derived cell lines: diagnostic and mechanistic implications.
Alberti G, Campanella C, Paladino L, Porcasi R, Bavisotto CC, Pitruzzella A, Graziano F, Florena AM, Argo A, de Macario EC, Macario AJ, Cappello F, Bucchieri F, Barone R, Rappa F. Alberti G, et al. Among authors: porcasi r. Front Biosci (Landmark Ed). 2022 Mar 15;27(3):97. doi: 10.31083/j.fbl2703097. Front Biosci (Landmark Ed). 2022. PMID: 35345329 Free article.
Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial.
Noto D, Petta S, Giammanco A, Spina R, Cabibbi D, Porcasi R, Caldarella R, Ciaccio M, Muratore R, Cefalù AB, Craxi A, Averna M. Noto D, et al. Among authors: porcasi r. Nutr Metab Cardiovasc Dis. 2022 May;32(5):1288-1291. doi: 10.1016/j.numecd.2022.01.024. Epub 2022 Jan 29. Nutr Metab Cardiovasc Dis. 2022. PMID: 35256232 Clinical Trial.
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease.
Pennisi G, Pipitone RM, Cabibi D, Enea M, Romero-Gomez M, Viganò M, Bugianesi E, Wong VW, Fracanzani AL, Sebastiani G, Berzigotti A, Di Salvo F, Giannone AG, La Mantia C, Lupo G, Porcasi R, Vernuccio F, Zito R, Di Marco V, Cammà C, Craxì A, de Ledinghen V, Grimaudo S, Petta S. Pennisi G, et al. Among authors: porcasi r. Liver Int. 2022 May;42(5):1037-1048. doi: 10.1111/liv.15232. Epub 2022 Mar 12. Liver Int. 2022. PMID: 35246921 Free article.
51 results